# A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

> **NCT07395687** · PHASE2 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 333 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** UBT251
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07395687
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-02
- **Primary completion:** 2027-01-14
- **Final completion:** 2027-02-18
- **Target enrollment:** 333 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07395687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07395687, "A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07395687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*